Veterinary Pain Management Market Size, Share, Competitive Landscape and Trend Analysis Report by Type, by Route of Administration, by Application and by Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2023-2032

Veterinary pain management is a crucial part of veterinary therapeutics. Pain not addressed appropriately in animals leads to delayed healing and exaggerated stress in already sick animals. Pain in animals could be due to surgeries, arthritis, and cancer that is accompanied with loss of appetite, aggression, and reduced activity. This could hinder the productivity of farm and pet animals. Ongoing research on lowering chronic pain in animals has made multiple options available to treat various causes of pain in animals that include pain medications, physical rehabilitation, acupuncture, laser therapy, and therapeutic massage.

The global veterinary pain management market has been witnessing significant growth, due to increase in adoption of pets as companions that increases the need of preventive treatments, medicines, and healthcare facilities for animals. Moreover, rise in need to maintain animal health and welfare in the developing countries and increase in adoption of pet insurance across the globe drive the growth of the market. In addition, increase in prevalence of animal diseases causing pain and inflammation fuels the market growth. However, lack of awareness towards serious disease conditions in companion animals restrains the growth of the market. On the contrary, increase in popularity of nonconventional and non-pharmaceutical treatment techniques and untapped emerging markets are anticipated to provide potential growth opportunity for the market.

The global veterinary pain management market is segmented on the basis of product, application, distribution channel, and region. By product, the market is differentiated into drugs and devices. Based on application, it is categorized into postoperative, cancer, arthritis, and others. Depending on distribution channel, it is divided into hospitals & clinics and pharmacy. Region wise, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Spain, Italy, and rest of Europe), Asia pacific (Japan, China, Singapore, India, South Korea, and rest of Asia-Pacific), LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

The key players of operating in the market are Bayer AG, Boehringer Ingelheim International GmbH., Merck & Co., Inc., The Chanelle Group, Norbrook Laboratories Limited, Eli Lilly and Company, Inc., Dechra Pharmaceuticals PLC., Ceva Sante Animale, IDEXX Laboratories, Inc., and Zoetis.

Key Benefits

• The report provides a quantitative analysis of the current market and estimation that assists to identify the current market opportunities.
• The report contains a thorough analysis of the factors that drive and restrict the growth of the global veterinary pain management market.
• The projections in the report are made by analyzing the current and future market trends for a period .
• In-depth analysis of drug types helps to understand the different types of drugs used for pain management in animals.
• Comprehensive analysis of the geographic regions is provided, which helps to better understand the region wise growth.
• Key players within the global veterinary pain management market are profiled to understand the competitor scenario.

  Veterinary Pain Management Market Report Highlights

Aspects	Details
By Type	NSAIDs Opioids Local Anesthetics Alpha-2 Agonists Disease-modifying Osteoarthritis Agents Others
By Route of Administration	Oral Parenteral Topical Devices Laser Therapy Devices Electromagnetic Therapy Devices
By Application	Postoperative Cancer Arthritis Others
By Distribution Channel	Hospitals & Clinics Pharmacy
By Region	North America  (U.S., Canada, Mexico) Europe  (France, Germany, Italy, Spain, UK, Rest of Europe) Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific) LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players	Bayer AG, IDEXX Laboratories, Inc., Merck & Co., Inc., The Chanelle Group, Dechra Pharmaceuticals PLC., Ceva Sante Animale, Norbrook Laboratories Limited, Eli Lilly and Company, Inc., Zoetis., Boehringer Ingelheim International GmbH.